Resources from the same session
1884MO - Phase II study of avelumab (Ave) plus intermittent axitinib (Axi) in previously untreated patients (pts) with metastatic renal cell carcinoma (mRCC): The TIDE-A study
Presenter: Roberto Iacovelli
Session: Mini oral session - Genitourinary tumours, non-prostate
Resources:
Abstract
Slides
Webcast
Invited Discussant 1883MO and 1884MO
Presenter: Deborah Mukherji
Session: Mini oral session - Genitourinary tumours, non-prostate
Resources:
Slides
Webcast